Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,450.8
-30.3 (-1.22%)

 

  • STI Straits Times Index
    2,450.8
    -30.3 (-1.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,500.8
    4.3 (0.29%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,311.1
    -431.4 (-1.82%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,223.2
    -56.5 (-1.72%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,087.8
    -258.7 (-1.11%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,842.8
    -75.2 (-1.53%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,147.9M
  • Value: 1,185.0M
  • Rise: 88
  • Fall: 215
  • Unch: 479

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.144-0.007
Clearbridge0.172+0.016
Jiutian Chemical0.046-
Singtel2.120-0.080
AsiaMedic0.024+0.002
CWX Global0.001-
Biolidics0.370+0.055
Genting Sing0.670-0.010
ComfortDelGro1.420-0.040
NetLink NBN Tr0.950-

World Indices

World Indices
Name Last Change
Nasdaq 10,633.0 -330.6
HSI 23,311.1 -431.4
HSCEI 9,371.2 -187.6
Jakarta 4,842.8 -75.2
Nikkei 225 23,087.8 -258.7
SSE Comp 3,223.2 -56.5
Shanghai A 3,378.0 -59.3
Shanghai B 246.6 -3.4
KOSPI 2,272.7 -60.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

IMMURON LIMITED IMMURON LIMITED
Updated on 24 Sep 2020 (End of trading day)
Last (AUD): 0.270 Change: - High: 0.270 Remarks: -
Change (%): - Low: 0.270
Open 0.270 Yesterday's Close 0.27
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 265,962 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.02067 Trailing EPS (AUD) e -0.02026 NAV (AUD) b 0.0306
PE a - Trailing PE f - Price / NAV b 8.8235
Dividend (AUD) d - Cash In Hand (AUD) g 0.0216 Issued & Paid-up Shares c 224,100,000
Dividend Yield (%) d - Price / Cash In Hand g 12.500 Treasury Shares h -
Beta - 75 Daysi 0.999 R-Squared - 75 Days(%)i 2.39 Market Cap (M) 60.507
Beta - 500 Daysi 0.977 R-Squared - 500 Days (%)i 0.87 Enterprise Value (M) 55.845
Piotroski F Score 3 Exchange Code IMC Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 162.58 Free Float (%) 91.7
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 29 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 30 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference IMMURON LIMITED ASX 60.507 - - 8.8235 -
Industry Pharmaceuticals: Major ASX 119.716 - - 10.0251 -
Local Peer STARPHARMA HOLDINGS LIMITED ASX 611.003 - - 19.5006 -
Local Peer AFT PHARMACEUTICALS LTD ASX 484.201 43.560 43.562 28.9737 -
Local Peer PYC THERAPEUTICS LIMITED ASX 469.053 - - 16.8421 -
Local Peer RECCE PHARMACEUTICALS LTD ASX 210.321 - - 91.1392 -
Local Peer ONCOSIL MEDICAL LIMITED ASX 99.432 - - 4.5455 -
Local Peer RACE ONCOLOGY LTD ASX 98.210 - - 17.2646 -
Local Peer PALLA PHARMA LTD ASX 93.831 - - 1.5198 -
Local Peer NOXOPHARM LTD ASX 87.429 - - 6.7881 -
Local Peer TBG DIAGNOSTICS LTD ASX 58.748 - - 6.4286 -
Local Peer INVION LTD ASX 55.036 - - 10.0000 -
Local Peer MEDLAB CLINICAL LIMITED ASX 47.545 - - 4.1667 -
Local Peer EXOPHARM LTD ASX 36.995 - - 7.3810 -
Other Local Peers PHARMAXIS (ASX), ACRUX (ASX), FIJI KAVA LTD (ASX), TALI DIGITAL LIMITED (ASX), CRESO PHARMA LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), CELLMID LIMITED (ASX), FARMAFORCE LTD (ASX)
Global Peer JOHNSON & JOHNSON NYSE 380,284.521 25.153 25.043 6.0384 2.596
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 215,744.397 30.610 29.889 4.0092 2.107
Global Peer MERCK & CO INC NYSE 208,991.101 21.232 19.944 7.5606 2.746
Global Peer PFIZER INC NYSE 200,047.680 12.294 14.118 3.1094 4.039
Global Peer ABBVIE INC NYSE 153,787.286 19.611 22.282 10.4561 4.222
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 146,084.123 108.975 67.860 11.9378 2.461
Global Peer ELI LILLY AND COMPANY NYSE 143,288.771 30.895 25.505 35.0089 1.724
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 132,959.331 38.662 - 2.7083 2.815
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 127,429.401 39.165 10.374 1.7923 2.309
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 125,791.664 21.543 20.509 13.9000 1.639
Other Global Peers GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), ROYALTY PHARMA PLC (NASDAQ), INNOVENT BIO (HKEx), CUREVAC NV (NASDAQ), CANSINOBIO-B (HKEx), REPLIGEN CORP (NASDAQ), SINOPHARM (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS (NASDAQ), BAIYUNSHAN PH (HKEx), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), HYGEIA HEALTH (HKEx), ALLAKOS INC (NASDAQ), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), TURNING POINT THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), HENLIUS-B (HKEx), PRINCIPIA BIOPHARMA INC (NASDAQ), CHINARES PHARMA (HKEx), CHINAGRANDPHARM (HKEx), AKESO-B (HKEx), CMS (HKEx), HEPALINK (HKEx), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), ADC THERAPEUTICS SA (NYSE), IGM BIOSCIENCES INC (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), TRAD CHI MED (HKEx), OPKO HEALTH INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ZYMEWORKS INC (NYSE), UNITED LAB (HKEx), OCUMENSION-B (HKEx), INNOCARE-B (HKEx), AKCEA THERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), SSY GROUP (HKEx), Y-MABS THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENERATION BIO CO (NASDAQ), AMNEAL PHARMACEUTICALS INC (NYSE), REPARE THERAPEUTICS INC (NASDAQ), Soho Global Health Tbk. (IDX), ATHENEX INC (NASDAQ), CSTONE PHARMA-B (HKEx), NURIX THERAPEUTICS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), CKLIFE SCIENCES (HKEx), PHATHOM PHARMACEUTICALS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), Kimia Farma Tbk. (IDX), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), TONGRENTANGCM (HKEx), KEROS THERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), ANNEXON INC (NASDAQ), PETIQ INC (NASDAQ), PROVENTION BIO INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), IMMUNOTECH-B (HKEx), TCR2 THERAPEUTICS INC (NASDAQ), AC IMMUNE SA (NASDAQ), HUA MEDICINE-B (HKEx), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), IGBB (Bursa), OCULAR THERAPEUTIX INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), TRICIDA INC (NASDAQ), 89BIO INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), SHINEWAY PHARM (HKEx), APPLIED THERAPEUTICS INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), FUSEN PHARM (HKEx), BEYONDSPRING INC (NASDAQ), IMARA INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), IMMUNIC INC (NASDAQ), DURECT CORP (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), BSTEAD (Bursa), XERIS PHARMACEUTICALS INC (NASDAQ), TOT BIOPHARM-B (HKEx), AQUESTIVE THERAPEUTICS INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), PHARMA (Bursa), CYCLERION THERAPEUTICS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), LANNETT CO INC (NYSE), HOOKIPA PHARMA INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), POLYPID LTD (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), MUSTANG BIO INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), VERU INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), ZHONGZHIPHARM (HKEx), DAWNRAYS PHARMA (HKEx), CH BIOTECH SER (HKEx), THERATECHNOLOGIES INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), OBSEVA SA (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), BIOMX INC (NYSE American), EVOLUS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), IX Biopharma (SGX), CORVUS PHARMACEUTICALS INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), KOTRA (Bursa), LANTERN PHARMA INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), Merck Tbk. (IDX), Hyphens Pharma (SGX), NEW RAY MEDIC (HKEx), IP (SET), NEP INTERLONG (HKEx), NOVAN INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), EYENOVIA INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), Phapros Tbk. (IDX), KITOV PHARMA LTD SPON ADS EACH REP 10 ORD SHS (R/S) (NASDAQ), PAK FAH YEOW (HKEx), EYEPOINT PHARMACEUTICALS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), NOVA (Bursa), CHARMACY PHAR (HKEx), ARIDIS PHARMACEUTICAL INC (NASDAQ), BIOHLDG (Bursa), NC HEALTHCARE (HKEx), BAUDAX BIO INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PAINREFORM LTD (NASDAQ), WAI YUEN TONG (HKEx), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), PURAPHARM (HKEx), SANAI HEALTH GP (HKEx), MANNATECH INC (NASDAQ), EXTRAWELL PHAR (HKEx), JCT (SET), AGEX THERAPEUTICS INC (NYSE American), ANNOVIS BIO INC (NYSE American), DARE BIOSCIENCE INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), SUN BIOPHARMA INC (NASDAQ), ENTERA BIO LTD (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), SUNZEN (Bursa), TITAN PHARMACEUTICAL INC (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), SINOLIFE UTD (HKEx), PASHUN INT'L (HKEx), CHINA SXT PHARMACEUTICALS INC (NASDAQ), TIMBER PHARMACEUTICALS INC (NYSE American), Merck Sharp Dohme Pharma Tbk. (IDX), TELIGENT INC NEW (NASDAQ), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.015
-5.26 %
10 Days -+0.005
+1.89 %
20 Days --0.060
-18.18 %
Medium Term Return 3 Months --0.030
-10.00 %
6 Months -+0.206
+321.88 %
1 Year -+0.165
+157.14 %
Long Term Return 2 Years --0.065
-19.40 %
3 Years -+0.090
+50.00 %
5 Years --0.176
-39.46 %
Annualised Return Annualised --
-9.55 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.050 - 0.950 Change From 1 Year Low +0.220 % Change From 1 Year Low (%) +440.00
Change From 1 Year High -0.680 % Change From 1 Year High (%) -71.58
2 Years Range 0.050 - 0.950 Change From 2 Years Low +0.220 % Change From 2 Years Low (%) +440.00
Change From 2 Years High -0.680 % Change From 2 Years High (%) -71.58
5 Years Range 0.050 - 0.950 Change From 5 Years Low +0.220 % Change From 5 Years Low (%) +440.00
Change From 5 Years High -0.680 % Change From 5 Years High (%) -71.58
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States. The HyperImmune Products segment comprises of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994 and is headquartered in Carlton, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
24 Sep 2020 0.270 0.270 0.270 0.270 265,962 -
23 Sep 2020 0.270 0.280 0.270 0.270 288,773 -
22 Sep 2020 0.270 0.275 0.270 0.270 262,288 -
21 Sep 2020 0.290 0.290 0.270 0.270 515,104 -
18 Sep 2020 0.280 0.290 0.275 0.285 320,947 -
17 Sep 2020 0.285 0.295 0.280 0.280 542,233 -
16 Sep 2020 0.305 0.305 0.285 0.285 1,392,365 -
15 Sep 2020 0.270 0.335 0.270 0.305 2,366,626 -
14 Sep 2020 0.270 0.280 0.270 0.275 461,149 -
11 Sep 2020 0.270 0.280 0.270 0.280 337,243 -
10 Sep 2020 0.275 0.290 0.270 0.270 652,012 -
09 Sep 2020 0.265 0.270 0.260 0.265 2,295,096 -
08 Sep 2020 0.280 0.285 0.275 0.285 272,959 -
07 Sep 2020 0.275 0.290 0.275 0.285 316,447 -
04 Sep 2020 0.285 0.295 0.275 0.275 1,531,991 -
03 Sep 2020 0.300 0.305 0.290 0.300 591,062 -
02 Sep 2020 0.305 0.305 0.285 0.290 2,637,630 -
01 Sep 2020 0.315 0.320 0.305 0.310 1,124,079 -
31 Aug 2020 0.320 0.345 0.320 0.330 1,226,695 -
28 Aug 2020 0.325 0.335 0.320 0.320 571,523 -
27 Aug 2020 0.335 0.340 0.320 0.320 872,826 -
26 Aug 2020 0.340 0.340 0.320 0.330 2,508,000 -
Summary
Current 2 Weeks
(11 Sep 2020 to 24 Sep 2020)
0.270 0.335 0.270 0.270 6,752,690 -
Previous 2 Weeks
(28 Aug 2020 to 10 Sep 2020)
0.325 0.335 0.270 0.270 11,219,494 -
4 Weeks from
(31 Jul 2020 to 27 Aug 2020)
0.375 0.390 0.270 0.320 34,402,182 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.